Ignite Creation Date:
2024-05-06 @ 2:13 PM
Last Modification Date:
2024-10-26 @ 1:26 PM
Study NCT ID:
NCT04242498
Status:
COMPLETED
Last Update Posted:
2023-10-17
First Post:
2020-01-23
Brief Title:
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma